Adaptive Biotechnologies Corporation Financial Ratios — ADPT

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-13.36	-11.02	-14.42	-20.32	-22.49	-29.68	-26.57	-11.31
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	59.22	64.67	73.82	77.1	68.06	68.75	55.63	59.72	74.24
EBITDA Margin (%)	-98.42	-78.61	-82.99	-146.72	-126.35	-96.74	-105.34	-76.05	-14.19
Operating Margin (%)	-113.49	-89.39	-92.15	-155.33	-135.39	-108.03	-118.4	-86.81	-20.62
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-111.4	-83.44	-80.65	-148.63	-134.31	-108.13	-132.32	-89.18	-21.47
Profit Margin (%)	-111.4	-83.44	-80.65	-148.63	-134.3	-108.03	-132.29	-89.12	-21.48
Net Income to Common Margin (%)	-111.4	-83.44	-80.65	-148.63	-134.3	-108.03	-132.29	-89.12	-21.48
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	37	108	112	108	99	89	79
ST Debt	- -	- -	- -	4	5	9	9	10	9
LT Debt	- -	- -	37	104	107	99	89	79	70
Total Debt/EBITDA	- -	- -	-0.52	-0.75	-0.57	-0.6	-0.55	-0.66	-2.01
Net Debt/EBITDA	2.25	1.26	1.37	0.86	0.71	0.5	0.36	0.35	1.79
Total Debt/EBIT	- -	- -	-0.47	-0.71	-0.53	-0.54	-0.49	-0.58	-1.39
Net Debt/EBIT	1.95	1.11	1.23	0.81	0.67	0.45	0.32	0.31	1.23
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-42.3	-13	-11.75	-3.34
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-46.16	-13.77	-12.07	-3.59
EBIT to Interest Expense	- -	- -	- -	- -	- -	-47.24	-14.61	-13.41	-4.85
Interest Expense	- -	- -	- -	- -	- -	4	14	12	12
Common Equity/Total Assets	-68.81	-88.94	-40.06	-45.83	-77.86	-107.29	-173.08	-241.73	-265.89
Long-Term Debt/Equity (%)	- -	- -	6.41	14.04	17.66	21.28	29	39.09	31.21
Long-Term Debt/Capital (%)	- -	- -	-11.13	-25.84	-17.58	-12.18	-8.55	-6.52	-5.5
Long-Term Debt/Total Assets (%)	- -	- -	4.01	9.35	11.55	11.53	13.52	14.67	13.7
Total Debt/Equity (%)	- -	- -	6.41	14.51	18.5	23.27	32.04	44.14	35.18
Total Debt/Capital (%)	- -	- -	-11.13	-26.72	-18.41	-13.31	-9.45	-7.36	-6.19
Total Debt/Total Assets (%)	- -	- -	4.01	9.66	12.1	12.61	14.94	16.57	15.44
Net Debt to Equity	37.98	21.32	-16.91	-16.61	-23.02	-19.4	-21.11	-23.67	-31.33
Net Debt/Capital (%)	25.48	15.68	22.7	23.41	18.64	9.99	5.86	3.8	5.23
EBITDA	-38	-44	-71	-144	-195	-179	-179	-136	-39
EBITDA-CapEx	-40	-50	-82	-163	-257	-196	-190	-140	-42
Operating Income (Loss)	-44	-50	-78	-153	-209	-200	-202	-155	-57

Liquidity (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	9.15	7.24	7.37	6.54	3.1	4.54	3.94	2.27	2.52
Current Ratio	9.77	7.93	7.82	6.91	3.54	5.12	4.66	2.89	3.34
Quick Ratio	9.41	7.45	7.53	6.64	3.26	4.9	4.37	2.69	3.08
CFO/Avg Current Liab	- -	-1.47	4.06	-1.63	-1.76	-1.65	-1.58	-1.02	-0.49
Common Equity/Total Assets	-68.81	-88.94	-40.06	-45.83	-77.86	-107.29	-173.08	-241.73	-265.89
Long-Term Debt/Equity (%)	- -	- -	6.41	14.04	17.66	21.28	29	39.09	31.21
Long-Term Debt/Capital (%)	- -	- -	-11.13	-25.84	-17.58	-12.18	-8.55	-6.52	-5.5
Long-Term Debt/Total Assets (%)	- -	- -	4.01	9.35	11.55	11.53	13.52	14.67	13.7
Total Debt/Equity (%)	- -	- -	6.41	14.51	18.5	23.27	32.04	44.14	35.18
Total Debt/Capital (%)	- -	- -	-11.13	-26.72	-18.41	-13.31	-9.45	-7.36	-6.19
Total Debt/Total Assets (%)	- -	- -	4.01	9.66	12.1	12.61	14.94	16.57	15.44
CFO/Total Liabilities	-5.94	-5.46	60.19	-40.11	-60.37	-46.86	-44.3	-28.26	-15.98
CFO/CapEx	-13.91	-5.12	18.34	-7.96	-3.12	-11.25	-14.61	-25.99	-15.54
Altman's Z-Score	-1.02	-1.67	3.58	12.09	5.9	- -	-1.98	-3.07	1.14

Working Capital (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	10.72	9.73	8.66	11.24	6.45	4.36	4.49	6.01
Days Sales Outstanding	- -	34.06	37.51	42.15	32.46	56.6	83.63	81.28	60.68
Inventory Turnover	- -	3.11	2.63	1.95	2.96	3.44	5.23	6.3	7.82
Days Inventory Outstanding	- -	117.19	138.53	187.38	123.36	106.26	69.81	57.95	46.7
Accounts Payable Turnover	- -	12.09	7.53	7.16	16.66	9.32	9.56	8.82	10.59
Accounts Payable Turnover Days	- -	30.19	48.5	50.99	21.91	39.15	38.18	41.39	34.45
Cash Conversion Cycle	- -	121.07	127.54	178.54	133.92	123.7	115.26	97.84	72.93
Inventory to Cash Days	- -	-83.13	-101.02	-145.22	-90.9	-49.66	13.82	23.33	13.98
Inventories	5	8	9	14	19	14	14	8	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	5	8	9	14	19	14	14	8	10

Enterprise Value (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	2,069	7,759	3,938	1,089	707	883	2,464
- Cash & Cash Equivalents	85	55	97	123	139	90	65	48	70
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	6
+ Total Debt	- -	- -	37	108	112	108	99	89	79
Enterprise Value	-192	-165	1,529	7,178	3,697	699	460	749	2,322
Total Capital	-249	-296	-329	-404	-607	-811	-1,046	-1,215	-1,278
Total Debt/Capital (%)	- -	- -	-11.13	-26.72	-18.41	-13.31	-9.45	-7.36	-6.19
Total Debt / EV	- -	- -	0.02	0.02	0.03	0.15	0.21	0.12	0.03
EV/Sales	- -	- -	17.98	72.96	23.95	3.77	2.7	4.19	8.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	7.44	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	7.06	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	2,069	7,759	3,938	1,089	707	883	2,464
Diluted Enterprise Value	-85	-55	2,009	7,743	3,911	1,107	741	924	2,479
EV per Share	- -	- -	22.11	54.71	26.34	4.9	3.18	5.09	15.31
TTM Sales	38	56	85	98	154	185	170	179	277
TTM EBITDA	-38	-44	-71	-144	-195	-179	-179	-136	-39
TTM Operating Income	-44	-50	-78	-153	-209	-200	-202	-155	-57
TTM Cash Flow to Firm	-35	-32	205	-150	-193	-180	-143	-84	-34
TTM Free Cash Flow to Firm	-32	-26	217	-131	-131	-163	-132	-80	-31

Multiples (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	9.55	-59.28	-30.07	-6.5	-4.86	-9.64	-57.27
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-192	-165	1,529	7,178	3,697	699	460	749	2,322
Low Price	- -	- -	24.05	15.19	24.01	5.96	2.6	2.28	5.96
EV/Sales	- -	- -	17.98	72.96	23.95	3.77	2.7	4.19	8.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-35.2	-35.53	-26.94	-7.41	-4.39	-3.91	-29.06
Price/Earnings High	- -	- -	-55.57	-58.95	-48.25	-20.59	-6.92	-6.52	-52.94
Price/Earnings Low	- -	- -	-24.25	-13.63	-16.26	-4.24	-1.67	-2.1	-15.2
Price/Book Value	- -	- -	-5.66	-15.17	-5.48	-1.18	-0.62	-0.68	-1.81
Price/Book Value Average	- -	- -	-6.61	-10.15	-7.77	-1.61	-0.86	-0.48	-1.27
Price/Book Value High	- -	- -	-10.43	-16.85	-13.91	-4.48	-1.36	-0.8	-2.31
Price/Book Value Low	- -	- -	-4.55	-3.9	-4.69	-0.92	-0.33	-0.26	-0.66
Price/Tangible Book Value	- -	- -	4.7	12.64	8.26	3.22	3.84	11.02	23.62
Price/Tangible Book Value Average	- -	- -	5.49	8.46	11.72	4.39	5.37	7.78	16.57
Price/Tangible Book Value High	- -	- -	8.66	14.04	20.98	12.18	8.46	12.99	30.2
Price/Tangible Book Value Low	- -	- -	3.78	3.25	7.07	2.51	2.04	4.19	8.67
Price/Sales	- -	- -	24.33	78.86	25.52	5.88	4.15	4.93	8.9
Price/Sales Average	- -	- -	28.38	52.8	36.18	8.01	5.81	3.48	6.24
Price/Sales High	- -	- -	44.81	87.61	64.79	22.24	9.15	5.81	11.37
Price/Sales Low	- -	- -	19.55	20.26	21.83	4.58	2.21	1.87	3.26
Price/Cash Flow	- -	- -	10.07	-51.84	-20.43	-5.92	-4.53	-9.27	-53.58
Price/Cash Flow Average	- -	- -	11.76	-34.71	-28.98	-8.07	-6.32	-6.55	-37.59
Price/Cash Flow High	- -	- -	18.56	-57.59	-51.89	-22.41	-9.97	-10.92	-68.49
Price/Cash Flow Low	- -	- -	8.1	-13.32	-17.49	-4.61	-2.41	-3.52	-19.66
Price/Free Cash Flow Average	- -	- -	11.15	-39.69	-42.64	-8.85	-6.79	-6.81	-40.18
Price/Free Cash Flow High	- -	- -	17.6	-65.86	-76.35	-24.59	-10.7	-11.36	-73.2
Price/Free Cash Flow Low	- -	- -	7.68	-15.23	-25.73	-5.06	-2.58	-3.66	-21.02
EV/Sales Average	- -	- -	27.68	52.65	36.01	8.1	6	3.71	6.3
EV/Sales High	- -	- -	44.11	87.46	64.62	22.34	9.35	6.04	11.43
EV/Sales Low	- -	- -	18.85	20.1	21.66	4.68	2.41	2.1	3.32
EV/EBITDA Average	2.25	1.26	-33.35	-35.88	-28.5	-8.38	-5.7	-4.88	-44.38
EV/EBITDA High	2.25	1.26	-53.15	-59.61	-51.14	-23.09	-8.87	-7.95	-80.54
EV/EBITDA Low	2.25	1.26	-22.71	-13.7	-17.14	-4.83	-2.28	-2.77	-23.39
EV/EBIT Average	1.95	1.11	-30.04	-33.89	-26.6	-7.5	-5.07	-4.28	-30.52
EV/EBIT High	1.95	1.11	-47.87	-56.3	-47.73	-20.68	-7.89	-6.96	-55.4
EV/EBIT Low	1.95	1.11	-20.45	-12.94	-16	-4.33	-2.03	-2.42	-16.09
Last Price	- -	- -	29.92	59.13	28.06	7.64	4.9	6	16.24
High Price	- -	- -	55.12	65.69	71.25	28.92	10.79	7.07	20.76
Enterprise Value Average	-85	-55	2,355	5,179	5,558	1,501	1,022	665	1,744
Enterprise Value High	-85	-55	3,752	8,604	9,973	4,139	1,591	1,081	3,165
Enterprise Value Low	-85	-55	1,603	1,978	3,343	867	410	377	919

Shares Outstanding	121	123	125	138	141	143	145	148	154
Diluted Weighted Avg Shares	106	106	69	131	140	143	144	147	152
Basic Weighted Avg Shares	106	106	69	131	140	143	144	147	152
Revenue per Share	0.36	0.53	1.23	0.75	1.1	1.3	1.18	1.22	1.83
EBITDA per Share	-0.36	-0.41	-1.02	-1.1	-1.39	-1.26	-1.24	-0.93	-0.26
Operating Income per Share	-0.41	-0.47	-1.13	-1.16	-1.49	-1.4	-1.4	-1.06	-0.38
Basic EPS, GAAP	-0.4	-0.44	-0.99	-1.11	-1.48	-1.4	-1.56	-1.08	-0.39
Basic EPS from Cont Ops	-0.4	-0.44	-0.99	-1.11	-1.48	-1.41	-1.56	-1.08	-0.39
Diluted EPS, GAAP	-0.4	-0.44	-0.99	-1.11	-1.48	-1.4	-1.56	-1.08	-0.39
Diluted EPS from Cont Ops	-0.4	-0.44	-0.99	-1.11	-1.48	-1.41	-1.56	-1.08	-0.39
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.33	-0.3	2.97	-1.14	-1.37	-1.29	-1.08	-0.65	-0.3
Free Cash Flow per Basic Share	-0.35	-0.36	2.81	-1.28	-1.81	-1.41	-1.16	-0.67	-0.32
Cash & Equivalents per Share	1.81	1.56	8.34	5.25	2.52	3.5	2.4	1.51	1.5
Book Value per Share	-2.36	-2.79	-5.28	-3.9	-5.12	-6.45	-7.93	-8.86	-8.99
Tangible Book Value per Share	-3.39	-3.69	6.36	4.68	3.4	2.37	1.28	0.54	0.69

Adaptive Biotechnologies Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)